Replies to post #1237 on Superstar Uplisters

[jtomm]

RIBT -- I would guess closer to 5m shares out after all is said and done.

The offering says 2.9m shares after the offering, but also says,

"The total number of shares of our common stock outstanding after this offering is based on 1,152,452 shares outstanding as of December 10, 2013 and excludes (i) 1,554,734 shares of common stock to be issued by July 1, 2014 to certain warrant holders in exchange for the cancellation of warrants to purchase up to 496,060 shares of common stock, and (ii) 134,250 shares to be issued by July 1, 2014 to a note investor.

After all the over-allotments, etc., I'd guess closer to 5m shares out.

[wow_happens28]

HIDDEN Value of RIBT number 1

RIBT has a rice bran oil plant in Brazil. It's being remodeled and got money today to finish it off, projected mid February 2014. It will have the highest quality commercial rice bran oils when completed. Cold Pressed is the best, but too expensive for commercial use. The kicker is that they call it a prototype plant. The CEO says we could use two in the USA now.

And the real kicker is that last April RIBT hired Mr. João Eduardo Luz de Almeida as President of Irgovel, Look at his bio, WAY WAY WAY over qualified.

"In his most recent position as Director of Special Projects he oversaw the launch of a new biodiesel business in Brazil. In his previous positions at Bunge, Brazil he served as Director of Ingredients, Director of Agrisolutions, and Business Relations Manager.

Mr. Luz de Almeida was also Global Director of Food Products at Bunge's headquarters in White Plains, New York where he was responsible for developing strategies for all food businesses for Bunge. In addition, during his career at Bunge he worked on the acquisition and integration of edible oil businesses in India and Russia"

RIBT CEO Short, who admitted at a CC that he is overqualified said Almeida's wife wanted to live in Brazil. The problem with that is that if you read my paste above, he was already there. It is my speculation that BG partners with RIBT in RBO plants. The negative is that RIBT will need another fund raise, but hopefully the stock will be much higher my mid August.

[wow_happens28]

Hidden Value of RIBT Number 2

RIBT holds 8 patents and more pending on nutraceuticals and pharmaceuticals.

From the year end

We hold eight U.S. patents relating to the production or use of Nutraceutical or HVF products. The patents are:

1.Patent Number 5,512,287 “PRODUCTION OF BETA-GLUCAN AND BETA-GLUCAN PRODUCT,” which issued on April 30, 1996 and expires in 2014.

2.Patent Number 5,985,344 “PROCESS FOR OBTAINING MICRONUTRIENT ENRICHED RICE BRAN OIL,” which issued November 16, 1999 and expires in 2018.

3.Patent Number 6,126,943 “METHOD FOR TREATING HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA, AND ATHEROSCLEROSIS,” which issued October 3, 2000 and expires in 2018.

4.Patent Number 6,303,586 B1 “SUPPORTIVE THERAPY FOR DIABETES, HYPERGLYCEMIA AND HYPOGLYCEMIA,” which issued October 16, 2001 and expires in 2018.

5.Patent Number 6,350,473 B1 “METHOD FOR TREATING HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA AND ATHEROSCLEROSIS,” which issued February 26, 2002 and expires in 2020.

6.Patent number 6,558,714 B2 “METHOD FOR TREATING HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA AND ATHEROSCLEROSIS” which issued May 06, 2003 and expires in 2021.

7.Patent number 6,733,799 “METHOD FOR TREATING HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA AND ATHEROSCLEROSIS” which issued May 11, 2004 and expires in 2023.

8.Patent number 6,902,739 “METHODS FOR TREATING JOINT INFLAMMATION, PAIN AND LOSS OF MOBILITY” which issued June 07, 2005 and expires in 2021

And more pending. RIBT was trying to raise some money for testing, but could not raise enough this time, they wanted $1,000,000. But I believe they have some "medical foods" now that could be sold through it's H & N acquisition.

Bill Gates gave Colorado State(Elizabeth Ryan, who knows RIBT and stabilized rice bran well) $1,000,000 to research rice and beans for various benefits, the study has been started a month or so ago, will take a year.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83635550&txt2find=bill|gates|rice|bran

They have a patent on a product named BiFlexin. It is rumored to be as strong as Vioxx for joint pain, but all natural and won't kill people. This is the one I believe CEO Short wanted the $1,000,000 for. I doubt is as good as Vioxx or they would have jumped all over it by now. But, could be pretty good.

So this stock could have some biotech unrational PE's later on?